Health Economics Services
Evaluate the cost-effectiveness and value of your intervention to inform resource allocation and policy decisions
We have one of Australia’s most experienced teams of health economists to help you incorporate economic evaluation into your product development from beginning to end.
If you're a product developer, demonstrating the economic benefits of new interventions is critical for commercial success. Health economics can estimate the cost-effectiveness of your intervention to support your market access strategy. Many countries rely on these economic evaluations to make funding allocation decisions and policies regarding their health sector budget.
CORE SERVICES
- Assist with funding applications
- Develop reimbursement strategies
- Assist with Pharmaceutical Benefits Advisory Committee (PBAC) submissions
- Consultation throughout all clinical trial stages
- Health economic study design
- Economic evaluation within clinical trials
- Modelled economic analyses
- Simulation modelling to estimate long-term health and economic impact
- Utilise routinely collected healthcare data, quality of life and preferences for care.
OUR HEALTH ECONOMISTS TACKLE THE BIGGEST EXISTING AND EMERGING HEALTH CHALLENGES INCLUDING:
- mental health
- ageing and dementia
- acute and critical care
- health services research
- diabetes and cardiovascular disease
- sexual health
- cancer
- other non-communicable diseases.
